DE60305741D1 - Neue halbsynthetische macrolidantibiotika der azalidreihe - Google Patents

Neue halbsynthetische macrolidantibiotika der azalidreihe

Info

Publication number
DE60305741D1
DE60305741D1 DE60305741T DE60305741T DE60305741D1 DE 60305741 D1 DE60305741 D1 DE 60305741D1 DE 60305741 T DE60305741 T DE 60305741T DE 60305741 T DE60305741 T DE 60305741T DE 60305741 D1 DE60305741 D1 DE 60305741D1
Authority
DE
Germany
Prior art keywords
macrolidantibiotics
azalid
synthetic
series
new half
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60305741T
Other languages
English (en)
Other versions
DE60305741T2 (de
Inventor
Nedjeljko Kujundzic
Krajacic Mirjana Bukvic
Karmen Brajsa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidelta doo
Original Assignee
Pliva Istrazivacki Institut doo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Istrazivacki Institut doo filed Critical Pliva Istrazivacki Institut doo
Publication of DE60305741D1 publication Critical patent/DE60305741D1/de
Application granted granted Critical
Publication of DE60305741T2 publication Critical patent/DE60305741T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60305741T 2002-12-12 2003-12-10 Neue halbsynthetische macrolidantibiotika der azalidreihe Expired - Fee Related DE60305741T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HR20020991 2002-12-12
HR20020991A HRP20020991A2 (en) 2002-12-12 2002-12-12 N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de
PCT/HR2003/000062 WO2004052904A2 (en) 2002-12-12 2003-12-10 Novel semisynthetic macrolide antibiotics of the azalide series

Publications (2)

Publication Number Publication Date
DE60305741D1 true DE60305741D1 (de) 2006-07-06
DE60305741T2 DE60305741T2 (de) 2007-06-14

Family

ID=32500425

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60305741T Expired - Fee Related DE60305741T2 (de) 2002-12-12 2003-12-10 Neue halbsynthetische macrolidantibiotika der azalidreihe

Country Status (25)

Country Link
US (1) US7342000B2 (de)
EP (1) EP1585753B1 (de)
JP (1) JP2006510660A (de)
KR (1) KR20050085555A (de)
CN (1) CN100335489C (de)
AR (1) AR042351A1 (de)
AT (1) ATE327999T1 (de)
AU (1) AU2003285599A1 (de)
BR (1) BR0316569A (de)
CA (1) CA2509599A1 (de)
CL (1) CL2003002585A1 (de)
CO (1) CO5640139A2 (de)
CY (1) CY1106321T1 (de)
DE (1) DE60305741T2 (de)
DK (1) DK1585753T3 (de)
ES (1) ES2266883T3 (de)
HK (1) HK1086273A1 (de)
HR (1) HRP20020991A2 (de)
IS (1) IS2309B (de)
MX (1) MXPA05006220A (de)
PL (1) PL377322A1 (de)
PT (1) PT1585753E (de)
RS (1) RS80204A (de)
RU (1) RU2328503C2 (de)
WO (1) WO2004052904A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020885B1 (en) 2002-11-11 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. SUBSTITUTED 9a-N-{N'-[4-(SULFONYL)PHENYLCARBAMOYL]}DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHROMYCIN A AND 5-O-DESOZAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHRONOLIDE A
JP2008526947A (ja) * 2005-01-14 2008-07-24 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 抗マラリア活性を有する９ａ−カルバモイル−γ−アミノプロピル−および９ａ−チオカルバモイル−γ−アミノプロピル−アザリド
ATE465741T1 (de) * 2005-01-14 2010-05-15 Glaxosmithkline Zagreb 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
EP2012776A2 (de) * 2006-05-03 2009-01-14 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. 9a-substituierte azalide

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43116B (en) 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
FR2473525A1 (fr) 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
BE892397A (nl) 1982-03-08 1982-07-01 Marchand Paul Wereldwijde draadloze telefonie voor 10 miljard abonnees
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4492688A (en) * 1983-11-25 1985-01-08 Pfizer Inc. Antibacterial cyclic ethers of 9-deoxo-9a-aza-9a-homoerythromycin A and intermediates therefor
US4464527A (en) 1983-06-30 1984-08-07 Pfizer Inc. Antibacterial 9-deoxo-9a-alkyl-9a-aza-9a-homoerythromycin A derivatives and intermediates therefore
WO1989004167A1 (en) 1987-11-10 1989-05-18 Pfizer Inc. Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives
HRP931480B1 (en) 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
WO1997035590A1 (en) 1996-03-25 1997-10-02 Platt Chris E 10-aza-9-deoxo-11-deoxy-erythromycin a and derivatives combined with sulfisoxazole
HRP990130B1 (en) * 1999-05-03 2004-06-30 Pliva D D HALOGEN DERIVATIVES 9a-N-(N'-ARYLCARBAMOYL)- AND 9a-N-(N'-ARYLTHIOCARBAMOYL)-9-DEOXO-9a-AZA-9a OF HOMOERYTHROMYCIN A
AU1727702A (en) * 2000-12-21 2002-07-01 Glaxo Group Ltd Macrolide antibiotics
HRP20010146B1 (en) 2001-02-28 2005-10-31 Pliva D.D. 9a-N-(N'-(PHENYLSULFONYL)CARBAMOYL) DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMYCIN A AND OF 5-O-DESOSAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHRONOLIDE A
HRP20020885B1 (en) 2002-11-11 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. SUBSTITUTED 9a-N-{N'-[4-(SULFONYL)PHENYLCARBAMOYL]}DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHROMYCIN A AND 5-O-DESOZAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHRONOLIDE A
HRP20020886A2 (en) 2002-11-11 2005-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. SUBSTITUTED 9a-N-[N'-(BENZENSULFONYL)CARBAMOYL-γ-AMINOPROPYL) AND 9a-N(N' -(?-CYANOETHIL)-N' -(b

Also Published As

Publication number Publication date
PL377322A1 (pl) 2006-01-23
US20060252709A1 (en) 2006-11-09
RU2328503C2 (ru) 2008-07-10
CO5640139A2 (es) 2006-05-31
PT1585753E (pt) 2006-08-31
JP2006510660A (ja) 2006-03-30
DK1585753T3 (da) 2006-10-02
AR042351A1 (es) 2005-06-15
KR20050085555A (ko) 2005-08-29
HRP20020991A2 (en) 2005-02-28
ES2266883T3 (es) 2007-03-01
RU2005121892A (ru) 2006-01-20
US7342000B2 (en) 2008-03-11
IS7875A (is) 2005-05-31
CN100335489C (zh) 2007-09-05
CY1106321T1 (el) 2011-10-12
EP1585753A2 (de) 2005-10-19
CL2003002585A1 (es) 2005-01-28
BR0316569A (pt) 2005-10-04
WO2004052904A2 (en) 2004-06-24
EP1585753B1 (de) 2006-05-31
CA2509599A1 (en) 2004-06-24
DE60305741T2 (de) 2007-06-14
MXPA05006220A (es) 2005-11-17
HK1086273A1 (en) 2006-09-15
WO2004052904A3 (en) 2004-09-02
IS2309B (is) 2007-10-15
CN1726222A (zh) 2006-01-25
ATE327999T1 (de) 2006-06-15
AU2003285599A8 (en) 2004-06-30
AU2003285599A1 (en) 2004-06-30
RS80204A (en) 2006-12-15

Similar Documents

Publication Publication Date Title
DE60328671D1 (de) Neue aminobenzamidderivate
ATE517887T1 (de) Neue 2-pyridincarbonsäureamidderivate
ATE389646T1 (de) Neue benzodioxole
NO20044046L (no) Substituerte hydroksyetylaminer
DE60215683D1 (de) Uhrgehäuse
IS7407A (is) Afleysing lausnarsambanda atorvastatínhálfkalsíums
ATE496887T1 (de) Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
ATE444290T1 (de) Oxazolderivate von tetracyclinen
ATE487694T1 (de) Neue phthalamidderivate
DE60305741D1 (de) Neue halbsynthetische macrolidantibiotika der azalidreihe
DE602004003054D1 (de) Neue 3-decladinosyl-9a-n-carbamoyl- und 9a-n-thiocarbamoylderivate von 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a
ITMI20020611A0 (it) Bruciatore
DE50309081D1 (de) Neue diketopyrrolopyrrolpigmente
FR2843451B1 (fr) Fronde du type lance-pierres
ITMI20021327A1 (it) Nuove ossialchilpiperazine
DE60216986D1 (de) Neue verwendung von pipatalin
ATE350379T1 (de) Substituierte benzdioxepine
FI20021222A (fi) Informaatiobittien limitys
FR2839258B1 (fr) Deambulateur-siege
DE60323088D1 (de) Leberschützende wirkung der 10-o-p-hydroxybenzoylaucubin
DE502004012380D1 (de) Bekleidungsstück
ITVR20020063U1 (it) Coprigambe
FI20020094A (fi) Nefriinintapaisten yhdisteiden käyttö
ATA18012003A (de) Schal
SE0302982D0 (sv) Motvikts-lastbrygga

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O, HR

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee